Scientific Sessions 2025  /  Controversies in Lifetime Management of Aortic Stenosis Patients Under 65 years: TAVR vs SAVR First Strategy  /  Is TAVR Increasing in the Young and What are the Outcomes?
Logo

American Heart Association

  78
  0

Final ID:

Is TAVR Increasing in the Young and What are the Outcomes?

  • Forcillo, Jessica  ( University of Montreal , Montreal , Quebec , Canada )
  • Eltchaninoff, Helene  ( Rouen University Hospital , Rouen , France )
  • Preventza, Ourania  ( University of Virginia , Houston , Texas , United States )
  • Ouzounian, Maral  ( Toronto General Hospital , Toronto , Ontario , Canada )
    • Author Disclosures:
    Jessica Forcillo: DO NOT have relevant financial relationships | Helene Eltchaninoff: No Answer | Ourania Preventza: DO have relevant financial relationships ; Consultant:Intressa Vascular :Active (exists now) ; Consultant:AbioMed:Past (completed) ; Consultant:Terumo Aortic :Active (exists now) ; Consultant:Artivion:Active (exists now) ; Consultant:Gore and Associates :Active (exists now) | Maral Ouzounian: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Controversies in Lifetime Management of Aortic Stenosis Patients Under 65 years: TAVR vs SAVR First Strategy

Saturday, 11/08/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
One and Done: Mechanical SAVR for Lifetime Management

Preventza Ourania, Goldstone Andrew, Bowdish Michael, Ouzounian Maral, Woo Y Joseph, Chikwe Joanna, Forcillo Jessica

TAVR for All Patients

Hahn Rebecca, Genereux Philippe, Makkar Raj, Mehran Roxana, Tchetche Didier, Webb John

More abstracts from these authors:
Panel

Ouzounian Maral, Forcillo Jessica

One and Done: Mechanical SAVR for Lifetime Management

Preventza Ourania, Goldstone Andrew, Bowdish Michael, Ouzounian Maral, Woo Y Joseph, Chikwe Joanna, Forcillo Jessica

You have to be authorized to contact abstract author. Please, Login
Not Available